8. Malignant Disease and Immunossuppression
| First line drugs | Second line drugs | Specialist drugs | Secondary care drugs |
| Recommended in both primary and secondary care | Alternatives (often in specific conditions) in both primary and secondary care; | Where a specialist input is needed (see introduction for definition) | Prescribing principally within secondary care only |
- General Information and contact details
- Side–effects of cytotoxic drugs
- Treatments for cytotoxic–induced side effects
- 8.1.1 Alkylating drugs
- 8.1.2 Anthracyclines and other cytotoxic antibiotics
- 8.1.3 Antimetabolites
- 8.1.4 Vinca alkaloids and etoposide
- 8.1.5 Other antineoplastic drugs
- 8.2.1 Antiproliferative immunosuppressants
- 8.2.2 Corticosteroids and other immunosuppressants
- 8.2.3 Anti–lymphocyte monoclonal antibodies
- 8.2.4 Other immunomodulating drugs
- 8.3.1 Oestrogens
- 8.3.2 Progestogens
- 8.3.3 Androgens
- 8.3.4 Hormone antagonists
Appendices
- Appendix 1 Advice on the maintenance of PICC lines
- Appendix 2 Advice on the maintenance of Central Venous Catheters
Last updated by: Carol Webb on 02-12-2011 11:27
Please click on the links below for more information
-
BNF
-
NICE
-
Summary of product characteristics
